Home
Search
BIO Digital

Speakers & Presenters

June 10-11 & 14-18, 2021
Register
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies

 

 

Featured Speakers
Dr. Anthony Fauci
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose,…
Julie Gerberding
Julie Gerberding, MD, MPH
EXECUTIVE VICE PRESIDENT AND CHIEF PATIENT OFFICER, MERCK & CO., INC.
Dr. Julie Gerberding is executive vice president and chief patient officer at Merck & Co., Inc., where she is responsible for global public policy,…
Peter Marks
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD AND DRUG ADMINISTRATION
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine…
Dr. Anthony Fauci
Julie Gerberding
Peter Marks
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Eric Adams
PRESIDENT & CEO, INMED PHARMACEUTICALS
InMed Pharmaceuticals Inc.
Vancouver, British Columbia, Canada
photo
Priya Agrawal, MD, MPH
CHIEF BEHAVIOURAL SCIENCE OFFICER, GLOBAL VACCINES, MERCK & CO., INC.
Building Vaccine Confidence: Evidence and Emotion
photo
Thaddeus Allen
VP, TRANSLATIONAL BIOLOGY, ANTICANCER BIOSCIENCE
Anticancer Bioscience
San Francisco, California, United States
photo
Niva Almaula
CHIEF BUSINESS OFFICER, PRECIRIX
Precirix
Brussels, New York, Belgium
photo
Gary Andres
REPUBLICAN STAFF DIRECTOR, U.S. HOUSE OF REPRESENTATIVES WAYS AND MEANS COMMITTEE
Pandemic and Profit: Why there must be a business model that works for the future
photo
Iain Armstrong
PARTNER, HGF LIMITED
CAR-T Therapies: Filing Trends, Opportunities,​ and Challenges to Patentability
Manchester, United Kingdom
photo
Phyllis Arthur
VICE PRESIDENT, INFECTIOUS DISEASES AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION
COVID-19 Therapeutics: Modality, Efficacy and Implications for Access
Fireside Chat with Thomas Triomphe, Executive Vice President, Sanofi Pasteur
Washington, United States
photo
Hartley Atkinson, PhD, MRPharmS
CEO, AFT PHARMACEUTICALS INC.
AFT Pharmaceuticals
Sydney, Australia
photo
David Baker, MBA
CHIEF EXECUTIVE OFFICER, VALLON PHARMA
Vallon Pharmaceuticals
Philadelphia, Pennsylvania, United States
photo
Chris Baldwin
CHIEF COMMERCIAL OFFICER, EXOPHARM LTD
Exopharm Ltd
East Melbourne, Australia
photo
Jason Barron
SENIOR COUNSEL, BECKMAN COULTER DIAGNOSTICS
Lessons from COVID on Innovation, Collaboration & Enforcement
photo
Abi Barrow
MANAGING PARTNER, CAMBRIDGE INNOVATION PARTNERS
The Speed of Success: Translating Research to COVID Vaccine Deployment
Cambridge, Massachusetts, United States
photo
Connor Barth
CO-FOUNDER & CHIEF EXECUTIVE OFFICER, INHERENT TARGETING
Inherent Targeting
Portland, Oregon, United States
photo
Casey Barton Behravesh, MS, DVM, DrPH, DACVPM
CAPTAIN, U.S. PUBLIC HEALTH SERVICE, DIRECTOR, ONE HEALTH OFFICE, NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES, CENTERS FOR DISEASE CONTROL AND PREVENTION
One Health Preparedness and Response: Translating Surveillance of Emerging Zoonotic Diseases into Biotechnology
photo
Dror Bashan
PRESIDENT & CEO, PROTALIX BIOTHERAPEUTICS
Protalix Biotherapeutics
Karmiel, Israel
photo
Amie Batson
EXECUTIVE DIRECTOR, WOMENLIFT HEALTH
Vaccine Business – Five minutes of fame or five-time Oscar winner?
photo
Beth Battaglino, RN-C
CEO, HEALTHYWOMEN
Return to Care in a Post-COVID World
Red Bank, New Jersey, United States
photo
Peter Bauer, MD
CHIEF GENOMIC OFFICER, CENTOGENE
Innovator Spotlight with Professor Peter Bauer, MD, Chief Genomic Officer at Centogene
Rosktock, Germany
photo
Jeff Baxter
PRESIDENT & CEO, VBI VACCINES
The Power of Vaccines in Combatting the Pandemic
Cambridge, Massachusetts, United States
photo
Ryan Beal
CEO / CO-FOUNDER, DYVE BIOSCIENCES
Dyve Biosciences
Newbury Park, California, United States
photo
Jonn Beeson
PARTNER, JONES DAY
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
photo
Atta Behfar
CEO, RION
Rion
Rochester, Minnesota, United States
photo
Geoffrey Bell
CEO, MICROBIOGEN PTY LTD
MicroBioGen
Lane Cove West, Australia
photo
Sonja Benkovich
DIRECTOR - ADMINISTRATION, AGASTIYA BIOTECH
Agastiya Biotech
Temecula, California, United States
photo
Stephen Bloch, MD
CHIEF EXECUTIVE OFFICER, EVOLVEIMMUNE THERAPEUTICS, INC.
EvolveImmune Therapeutics
Westport, Connecticut, United States
photo
Timothy A. Bouley
CO FOUNDER & CEO, BIOFEYN
One Health Preparedness and Response: Translating Surveillance of Emerging Zoonotic Diseases into Biotechnology
Paris, France
photo
Albert Bourla, PhD, DVM
CHAIRMAN AND CHIEF EXECUTIVE OFFICER, PFIZER INC.
Breaking Barriers in Vaccine Development: A Conversation with Dr. Albert Bourla, Chairman and Chief Executive Officer of Pfizer
New York, New York, United States
photo
Melissa Bradford-Klug, MBA
CHIEF BUSINESS OFFICER, CITRINE MEDICINE
Citrine Medicine
Belmont, Massachusetts, United States
photo
Chris Bradley
CEO , LOKI THERAPEUTICS
Loki Therapeutics
New York, New York, United States
photo
Robert Bradway
CHAIRMAN & CEO, AMGEN INC.
A Conversation with Robert Bradway, Chief Executive Officer, Amgen
Thousand Oaks, California, United States
photo
Scott Braunstein, MD
CEO & DIRECTOR, MARINUS PHARMACEUTICALS
Marinus Pharmaceuticals
Radnor, Pennsylvania, United States
photo
Linda Budzinski
DIRECTOR OF OUTREACH, SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Return to Care in a Post-COVID World
Reston, Virginia, United States
photo
Molly Cameron
CORPORATE COMMUNICATIONS MANAGER, ORCHARD THERAPEUTICS NA
Orchard Therapeutics
Boston, Massachusetts, United States
photo
Patrizia Cavazzoni, MD
ACTING DIRECTOR FOR CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), DEPUTY CENTER DIRECTOR FOR OPERATIONS, THE U.S. FOOD AND DRUG ADMINISTRATION TECHNOLOGY TRANSFER PROGRAM
FDA Town Hall
Silver Spring, Maryland, United States
photo
Sharon Chan
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
Shanghai, China
photo
DongOck Chang
MANAGER , Y-BIOLOGICS INC.
Y-Biologics Inc
Daejeon ,
photo
Yu Chen
VP OF APAC, THOUSAND OAKS BIOPHARMACEUTICALS
Thousand Oaks Biopharmaceutical
Pleasanton, California, United States
photo
Wei-Kuang Chi
VICE PRESIDENT, R&D, DEVELOPMENT CENTER FOR BIOTECHNOLOGY
Development Center for Biotechnology
Taipei City, Taiwan
photo
Dohyun Cho
CHIEF OPERATING OFFICER, ENZYCHEM LIFESCIENCES
Enzychem Lifesciences
Englewood Cliffs, New Jersey, United States
photo
Will Chou, MD, MBA
CEO, ARUVANT SCIENCES, INC.
Aruvant Sciences, Inc.
New York, New York, United States
photo
Anita Cicero, JD
DEPUTY DIRECTOR, JOHNS HOPKINS CENTER FOR HEALTH SECURITY
The Power of Vaccines in Combatting the Pandemic
Baltimore, Maryland, United States
photo
Dan Close
, 490 BIOTECH INC.
490 BioTech
Knoxville, Tennessee, United States
photo
Nanette Cocero
GLOBAL PRESIDENT, VACCINES, PFIZER INC.
Vaccine Business – Five minutes of fame or five-time Oscar winner?
New York, New York, United States
photo
Tony Coles, MD
CHIEF EXECUTIVE OFFICER, CEREVEL THERAPEUTICS, LLC
Fireside Chat with Tony Coles, MD, Chief Executive Officer and Chairperson of the Board of Directors, Cerevel
Cambridge, Massachusetts, United States
photo
Francis Collins, MD, PhD
DIRECTOR, NATIONAL INSTITUTES OF HEALTH (NIH)
Fireside Chat with Francis Collins, Director of the NIH
Rockville, Maryland, United States
photo
Max Cynader
CEO, PRIMARY PEPTIDES INC
Primary Peptides Inc
Vancouver, British Columbia, Canada
photo
Yu-Ming Dammann
ASSOCIATE GENERAL COUNSEL, GILEAD SCIENCES
CAR-T Therapies: Filing Trends, Opportunities,​ and Challenges to Patentability
photo
Kanad Das
EXECUTIVE DIRECTOR, BI VENTURE FUND, BOEHRINGER INGELHEIM
Raising Capital Today, Part 1 - From Start-Up to pre-IPO
Ridgefield, Connecticut, United States
photo
Sugato De, MS
VICE PRESIDENT - TECHNICAL, PAREXEL INTERNATIONAL
The Future of Clinical Trials: Lessons from COVID-19
photo
Matt Delaney, MBA
GLOBAL VICE PRESIDENT SALES & MARKETING, CYTOVANCE BIOLOGICS
Cytovance Biologics
Oklahoma City, Oklahoma, United States
photo
Jim DeMesa, MD, BS, MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER, EMERALD HEALTH SCIENCES
Emerald Health Pharmaceuticals
San Diego, California, United States
photo
Rahul Dhanda
CO-FOUNDER, CEO, PRESIDENT & DIRECTOR, SHERLOCK BIOSCIENCES
Diagnosing the Future: The Impact of the COVID-19 Pandemic on Diagnostics
Cambridge, Massachusetts, United States
photo
David Dodd
CHAIRMAN, PRESIDENT & CEO, GEOVAX LABS, INC
Vaccine Business – Five minutes of fame or five-time Oscar winner?
GeoVax Labs, Inc.
Smyrna, Georgia, United States
photo
Eric Dube, PhD
PRESIDENT & CEO, TRAVERE THERAPEUTICS, INC.
Patient Perspectives: Elevating Our Voices to Advance Innovation
San Diego, California, United States
photo
Denis Dufrane
CEO & FOUNDER, NOVADIP BIOSCIENCES SA
NOVADIP Biosciences sa
Mont-Saint-Guibert, Belgium
photo
Zac Durant
SENIOR DIRECTOR OF BUSINESS ALLIANCES AND STRATEGY, PICOMOLE
Picomole
Boston, Massachusetts, United States
photo
Rajeev Dutt
PRESIDENT, CHIEF EXECUTIVE OFFICER, CO-FOUNDER, AI DYNAMICS
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
Stolberg, Germany
photo
Mark Edwards
MANAGING DIRECTOR, BIOSCIENCE ADVISORS, INC.
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
Walnut Creek, California, United States
photo
Ivy Elkins
CO-FOUNDER, EGFR RESISTERS
The Burden of Rare Disease and Access to Treatments
photo
Sébastien Enault
CHIEF BUSINESS OFFICER, MEDINCELL
MedinCell
Jacou, France
photo
Steven Engle
CHIEF EXECUTIVE OFFICER, COHBAR INC.
CohBar, Inc.
Menlo Park, California, United States
photo
Stanley Erck
PRESIDENT & CEO, NOVAVAX, INC
Global Pandemic Preparedness – It takes a globe....
Gaithersburg, Maryland, United States
photo
Robert Fallon
PRESIDENT & CEO, PHOSPLATIN THERAPEUTICS
Phosplatin Therapeutics Inc.
New York, New York, United States
photo
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
How to End the HIV/AIDS Epidemic: Collaboration and Investment to Address Global Unmet Needs and Prioritize Research
photo
Peter Fedichev, PhD
CEO, GERO PTE. LTD.
Gero
Singapore, Singapore
photo
Simone Fishburn, PhD
VICE PRESIDENT & EDITOR IN CHIEF, BIOCENTURY INC.
A More Perfect Partnership: State of the Pharma and Biotech Union
Redwood City, California, United States
photo
Charles Fisher
FOUNDER AND CEO, UNLEARN.AI
Unlearn.AI
San Francisco, California, United States
photo
William Fitzsimmons
FOUNDER AND CHAIR, TUTELA PHARMACEUTICALS INC
Tutela Pharmaceuticals Inc.
Vernon Hills, Illinois, United States
photo
Adi Frish
CHIEF CORPORATE & BUSINESS DEVELOPMENT OFFICER, REDHILL BIOPHARMA
RedHill Biopharma
Tel Aviv, Israel
photo
Steven Fruchtman, MD
PRESIDENT & CEO, ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics, Inc.
Newtown, Pennsylvania, United States
photo
Toshio Fujimoto, MD
GENERAL MANAGER OF SHONAN HEALTH INNOVATION PARK, TAKEDA PHARMACEUTICAL COMPANY
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
Fujisawa, Kanagawa, Japan
photo
Jeffrey Galvin
CHIEF EXECUTIVE OFFICER, AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
American Gene Technologies
Rockville, Maryland, United States
photo
Arpa Garay
PRESIDENT, GLOBAL PHARMACEUTICALS, COMMERCIAL ANALYTICS & DIGITAL MARKETING, MERCK & CO., INC.
COVID-19 Therapeutics: Modality, Efficacy and Implications for Access
Gwynedd, Pennsylvania, United States
photo
Julie Gerberding, MD, MPH
EXECUTIVE VICE PRESIDENT AND CHIEF PATIENT OFFICER, MERCK & CO., INC.
How to End the HIV/AIDS Epidemic: Collaboration and Investment to Address Global Unmet Needs and Prioritize Research
Gwynedd, Pennsylvania, United States
photo
Geno Germano
PRESIDENT & CHIEF EXECUTIVE OFFICER, ELUCIDA ONCOLOGY, INC
Elucida Oncology
Monmouth Junction, New Jersey, United States
photo
David Giljohann
CEO, EXICURE, INC.
Exicure
Chicago, Illinois, United States
photo
Jacob Glanville
FOUNDER/CEO/PRESIDENT, CENTIVAX, INC.
Centivax, Inc.
South San Francisco, California, United States
photo
Serghei Glinca
CEO, CRYSTALSFIRST GMBH
CrystalsFirst
Marburg, Germany
photo
Mark Godsy, LLB
CHIEF EXECUTIVE OFFICER, SHACKELFORD PHARMA INC.
Shackelford Pharma Inc.
Vancouver, British Columbia, Canada
photo
Jennifer Good
PRESIDENT & CEO, TREVI THERAPEUTICS
Trevi Therapeutics, Inc.
New Haven, Connecticut, United States
photo
Steven Gourlay
CHIEF EXECUTIVE OFFICER, ACTINOGEN MEDICAL
Actinogen Medical Limited
Sydney, Australia
photo
Luba Greenwood, JD
MANAGING PARTNER, BINNEY STREET CAPITAL, LLC
Commercialization Is Key: Digital Medicine Commercialization Trends and Opportunities
photo
Jessica Grossman
CEO, IGGENIX
IgGenix
Tiburon, California, United States
photo
Mary Haak-Frendscho, PhD
CEO, SPOTLIGHT THERAPEUTICS INC.
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
Hayward, California, United States
photo
Richard Haass
PRESIDENT, COUNCIL ON FOREIGN RELATIONS
Fireside Chat with Richard N. Haass, President, Council on Foreign Relations
photo
Brendon Hale, PhD
SENIOR PRINCIPAL RESEARCH SCIENTIST, OPTUM LABS
Commercialization Is Key: Digital Medicine Commercialization Trends and Opportunities
photo
Sean Hall
CEO, MEDLAB
Medlab Clinical LTD
Sydney, Australia
photo
Michael Handley
CEO, CYTOCOM, INC.
Cytocom, Inc.
Fort Collins, Colorado, United States
photo
Dror Harats
CHIEF EXECUTIVE OFFICER, VASCULAR BIOGENICS LTD.
VBL Therapeutics
Modi'in, Israel
photo
Susie Harborth
EXECUTIVE VICE PRESIDENT, BUSINESS OPERATIONS, BREAKTHROUGH PROPERTIES
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
photo
Shelley Hartman
CHIEF EXECUTIVE OFFICER, AEGLE THERAPEUTICS CORP.
Aegle Therapeutics Corp
Woburn, Massachusetts, United States
photo
Richard Hatchett, MD
CHIEF EXECUTIVE OFFICER, COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
Global Pandemic Preparedness – It takes a globe....
London, United Kingdom
photo
Lou Hawthorne
CHIEF EXECUTIVE OFFICER, NANOTICS, LLC
NaNotics, LLC
Mill Valley, California, United States
photo
Koki Hayamizu
, NIPPON CHEMIPHAR CO., LTD.
Nippon Chemiphar
Tokyo, Japan
photo
Jing He
FOUNDER, GEN LAW FIRM
The Patent Policy Landscape, Post-COVID
photo
Marc Hedrick
PRESIDENT/CEO, PLUS THERAPEUTICS
Plus Therapeutics
Austin, Texas, United States
photo
Jill Heemskerk, PhD
DEPUTY DIRECTOR, NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) AND RAPID ACCELERATION OF DIAGNOSTICS (RADX), NATIONAL INSTITUTES OF HEALTH
Diagnosing the Future: The Impact of the COVID-19 Pandemic on Diagnostics
photo
Karen Heichman, PhD
DEPUTY DIRECTOR, BILL AND MELINDA GATES FOUNDATION
Innovator Spotlight with Karen Heichman, Deputy Director of Diagnostics, Global Health Division at the Bill & Melinda Gates Foundation​
Seattle, Washington, United States
photo
Lee Helman, MD
PROFESSOR, USC, HEAD BASIC AND TRANSLATIONAL RESEARCH, CHILDREN'S CENTER FOR CANCER AND BLOOD DISEASES, CHILDREN'S HOSPITAL LOS ANGELES
Cancer Collaborations: Accelerating Therapy Development & Commercialization
photo
Daja Herald
SR MARKETING MANAGER, WUXI APPTEC
WuXi AppTec
St. Paul, Minnesota, United States
photo
James Hickman
CHIEF SCIENTIST, HESPEROS, INC.
Hesperos, Inc.
Orlando, Florida, United States
photo
Katherine High, MD
PRESIDENT, THERAPEUTICS, ASKBIO
Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities
Philadelphia, Pennsylvania, United States
photo
Natalie Holles
FORMER PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES THERAPEUTICS, AN ASTELLAS COMPANY
Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities
San Francisco, California, United States
photo
Jennifer Holmgren
CHIEF EXECUTIVE OFFICER, LANZATECH
Innovator Spotlight with Dr. Jennifer Holmgren, CEO of LanzaTech
Skokie, Illinois, United States
photo
Sönke Holtorf, PhD
DIRECTOR HBC | DIRECTORATE 1.1.1.1, EUROPEAN PATENT OFFICE
CAR-T Therapies: Filing Trends, Opportunities,​ and Challenges to Patentability
Munich, Germany
photo
John Houston
PRESIDENT & CEO , ARVINAS, INC.
Arvinas, Inc.
New Haven, Connecticut, United States
photo
Dar-Jen Hsieh
CEO, ACRO BIOMEDICAL CO., LTD.
ACRO Biomedical Co., Ltd.
Kaohsiung City, Taiwan
photo
Matthew Hudes
CEO, BDLBIOLOGX
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
Vancouver, Washington, United States
photo
Albert Hwang, MD
MANAGING DIRECTOR, MORGAN STANLEY
Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities
New York, New York, United States
photo
Robert Iannone
EXECUTIVE VICE PRESIDENT, RESEARCH AND DEVELOPMENT, JAZZ PHARMACEUTICALS, INC.
Cancer Collaborations: Accelerating Therapy Development & Commercialization
Philadelphia, Pennsylvania, United States
photo
Mandy Jackson
MANAGING EDITOR, SCRIP INTELLIGENCE
Cancer Collaborations: Accelerating Therapy Development & Commercialization
LA MESA, California, United States
photo
Allison Jeynes-Ellis
CHIEF EXECUTIVE OFFICER, AVILLION LLP
Avillion LLP
London, United Kingdom
photo
Troels Jordansen
CEO, GLYCOSTEM THERAPEUTICS
Glycostem Therapeutics B.V.
Oss, Netherlands
photo
Lisa Jorgenson
DEPUTY DIRECTOR GENERAL FOR PATENTS AND TECHNOLOGY, WORLD INTELLECTUAL PROPERTY ORGANIZATION
The Patent Policy Landscape, Post-COVID
photo
Aman Kant
CBO, INVENIAI LLC
InveniAI LLC
Guilford, Connecticut, United States
photo
Jason Kelly
CEO & CO-FOUNDER, GINKGO BIOWORKS
Innovator Spotlight with Jason Kelly, CEO of Ginkgo Bioworks
Boston, Massachusetts, United States
photo
Annie Kennedy
CHIEF OF POLICY AND ADVOCACY, EVERYLIFE FOUNDATION FOR RARE DISEASES
The Burden of Rare Disease and Access to Treatments
Washington, United States
photo
James Kenney
Novel Reimbursement Approaches: Overcoming Barriers
photo
Rachna Khosla
VICE PRESIDENT, BUSINESS DEVELOPMENT, AMGEN BUSINESS DEVELOPMENT
Market Hyperactivity: Bane of Biotech Deal-makers?
Newbury Park, California, United States
photo
Sunyoung Kim
CEO, HELIXMITH CO., LTD
Helixmith Co., Ltd
Seoul,
photo
Bong-Seog Kim, PhD, MD
CTO, BORYUNG PHARMACEUTICAL CO., LTD.
Boryung Pharmaceutical Co., Ltd.
Seoul,
photo
Roy Kimura
CEO, MODULUS DISCOVERY, INC.
Modulus Discovery, Inc.
Cambridge, Massachusetts, United States
photo
Michael Kokesh, JD, BS, BA
PRESIDENT & CEO, VICARDIA THERAPEUTICS, INC.
ViCardia Therapeutics Inc.
San Francisco, California, United States
photo
Ella Korets-Smith
CHIEF BUSINESS OFFICER, VIRICA BIOTECH
Virica Biotech
Toronto, Ontario, Canada
photo
Mark Kotter
CEO AND FOUNDER, BIT.BIO
bit.bio
Cambridge, United Kingdom
photo
Thomas Kowalski
PRESIDENT & CEO, TEXAS HEALTHCARE & BIOSCIENCE INSTITUTE
Biotechnology State Economic Development Post-COVID: Where Public-Private Partnerships Succeed
Austin, Texas, United States
photo
Achim Krauss
PRESIDENT AND CEO, AXEROVISION, INC.
AxeroVision, Inc.
Carlsbad, California, United States
photo
Jenelle Krishnamoorthy, PhD
INTERIM VICE PRESIDENT, GLOBAL PUBLIC POLICY, MERCK & CO., INC.
Fixing the Economics of Antibiotic Development—Before It’s Too Late
Kenilworth, New Jersey, United States
photo
Hannah Kuchler
PHARMACEUTICALS CORRESPONDENT, FINANCIAL TIMES
Building Vaccine Confidence: Evidence and Emotion
New York, New York, United States
photo
Yoshi Kumagai
PRESIDENT AND CEO, ORTHOTROPHIX, INC.
OrthoTrophix, Inc.
San Mateo, California, United States
photo
Edwin Kwon
CFO, EUTILEX
Eutilex
Seoul,
photo
Jordan Lancaster
CHIEF EXECUTIVE OFFICER, AVERY THERAPEUTICS, INC.
Avery Therapeutics, Inc.
Tucson, Arizona, United States
photo
Heidi Larson, PhD
DIRECTOR, THE VACCINES CONFIDENCE PROJECT
Building Vaccine Confidence: Evidence and Emotion
photo
Julie Latiuk
OFFICE MANAGER, DYADIC INTERNATIONAL, INC
Dyadic International, Inc.
Jupiter, Florida, United States
photo
Jessica Leccese
SENIOR REGULATORY AFFAIRS SPECIALIST, HEALTH CANADA
Health Canada/New Substances Assessment and Control Bureau
Ottawa, Ontario, Canada
photo
Luke Lee
CHIEF EXECUTIVE OFFICER, SHAPERON INC.
Shaperon Inc.
Seoul,
photo
Andrew Lees
, FINA BIOSOLUTIONS, LLC
Fina Biosolutions
Rockville, Maryland, United States
photo
Christine Lemke
CO-FOUNDER, CO-CHIEF EXECUTIVE OFFICER, & PRESIDENT, EVIDATION HEALTH
Commercialization Is Key: Digital Medicine Commercialization Trends and Opportunities
San Mateo, California, United States
photo
Emily Leproust, PhD
CEO, TWIST BIOSCIENCE
Fireside Chat with CEO and Co-Founder of Twist Bioscience, Dr. Emily Leproust
South San Francisco, California, United States
photo
Rachael Lester
VICE PRESIDENT, CORPORATE DEVELOPMENT, HARPOON THERAPEUTICS
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
South San Francisco, California, United States
photo
Jeremy Levin, DPhil, MB BChir
CHAIRMAN OF THE BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICER, OVID THERAPEUTICS INC.
Fireside Chat with Richard N. Haass, President, Council on Foreign Relations
New York, New York, United States
photo
Kun-Po Li
MANAGER, CLINICAL DEVELOPMENT, IMMUNWORK, INC.
Immunwork, Inc.
Taipei City, Taiwan
photo
Joshua Liang
CHIEF EXECUTIVE OFFICER, BOARD DIRECTOR, CLOVER BIOPHARMACEUTICALS
Vaccine Business – Five minutes of fame or five-time Oscar winner?
photo
Matt Liddelow
CEO & MANAGING DIRECTOR, NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
NeuroScientific Biopharmaceuticals Ltd
Cottesloe, Australia
photo
Mary Lindenstein Walshok, PhD
ASSOCIATE VICE CHANCELLOR FOR PUBLIC PROGRAMS AND DEAN OF EXTENSION, UNIVERSITY OF CALIFORNIA, SAN DIEGO
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
La Jolla, California, United States
photo
Klaus Lindpaintner
CSO/CMO, INTERVENN BIOSCIENCES
InterVenn Bioscience
South San Francisco, California, United States
photo
Robert Linke, MBA
CEO, OSMOL THERAPEUTICS, INC.
Osmol Therapeutics, Inc
New Haven, Connecticut, United States
photo
Casey Lippmeier
VP, RESEARCH AND DEVELOPMENT, CONAGEN, INC
Conagen
Bedford, Massachusetts, United States
photo
Roy Lipski
CHIEF EXECUTIVE OFFICER, CREO, INC.
Creo Inc
Fort Worth, Texas, United States
photo
Heinz Lubenau
CHIEF EXECUTIVE OFFICER, VAXIMM AG
VAXIMM
Basel, Switzerland
photo
Michael Lutzenburg
HEAD OF STRATEGIC PARTNERING , BOEHRINGER INGELHEIM ANIMAL HEALTH
Boehringer Ingelheim Animal Health
Ingelheim, Germany
photo
Maria Maccecchini
PRESIDENT & CEO, ANNOVIS BIO, INC.
Annovis Bio
Berwyn, Pennsylvania, United States
photo
Sarah MacDonald
EXECUTIVE DIRECTOR, LIFE SCIENCE CARES, INC.
Life Science Cares
Cambridge, Massachusetts, United States
photo
Ibs Mahmood
CEO, AMO PHARMA
AMO Pharma
London, United Kingdom
photo
Tapan Maniar, PhD
GENENTECH SITE HEAD OF RESEARCH TECHNOLOGIES, PHARMA PARTNERING, GENENTECH AND ROCHE
Machine Learning: Transforming Drug Discovery and Development
South San Francisco, California, United States
photo
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD AND DRUG ADMINISTRATION
FDA Town Hall
Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities
Silver Spring, Maryland, United States
photo
Tyler Martin
CEO, ADJUVANCE TECHNOLOGIES, INC.
Adjuvance Technologies
Lincoln, Nebraska, United States
photo
Marc Martin-Casas
SEED INVESTMENTS & DEVELOPMENT, ILLUMINA ACCELERATOR
Illumina Accelerator
San Mateo, California, United States
photo
Alexander Martinez
CEO, INTRINSIC MEDICINE
Intrinsic Medicine, Inc.
Des Moines, Washington, United States
photo
Sabrina Martucci Johnson
PRESIDENT & CEO, DARé BIOSCIENCE
Daré Bioscience
San Diego, California, United States
photo
Robert Matthews
CEO, KAER BIOTHERAPEUTICS
KAER Biotherapeutics Corporation
Escondido, California, United States
photo
Andrea Mazzocchi
CHIEF EXECUTIVE OFFICER, KNOWN MEDICINE
Known Medicine
Salt Lake City, Utah, United States
photo
Joe McCann
CEO, POINT BIOPHARMA
POINT Biopharma
Toronto, Ontario, Canada
photo
Joshua McClure
CEO, MAXWELL BIOSCIENCES
Maxwell Biosciences, Inc
Austin, Texas, United States
photo
Michael McCullar, PhD
CEO, ONQUALITY PHARMACEUTICALS
OnQuality Pharmaceuticals
Seattle, Washington, United States
photo
Andrew McKee, MD
FOUNDER, CEO, AND PRESIDENT, HEADLAND STRATEGY GROUP
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
San Francisco, California, United States
photo
Michelle McMurry-Heath, MD, PhD
PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
Breaking Barriers in Vaccine Development: A Conversation with Dr. Albert Bourla, Chairman and Chief Executive Officer of Pfizer
Fireside Chat with Tony Coles, MD, Chief Executive Officer and Chairperson of the Board of Directors, Cerevel
Washington, District of Columbia, United States
photo
David Mead
CEO, VARIGEN BIOSCIENCES CORPORATION
Varigen Biosciences
Madison, Wisconsin, United States
photo
Travis Mickle, PhD
PRESIDENT & CEO, KEMPHARM, INC
Lessons from COVID on Innovation, Collaboration & Enforcement
Celebration, Florida, United States
photo
Debra Miller
CHIEF EXECUTIVE OFFICER & FOUNDER, CURE DUCHENNE
Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities
Newport Beach, California, United States
photo
Tim Miller, PhD
CO-FOUNDER, PRESIDENT & CEO, FORGE BIOLGOICS
Forge Biologics
Grove City, Ohio, United States
photo
Brian Miller
CEO AND CO-FOUNDER, SENTIEN BIOTECHNOLOGIES, INC.
Sentien Biotechnologies, Inc.
LEXINGTON, Massachusetts, United States
photo
Elizabeth Mily
EXECUTIVE VICE PRESIDENT, STRATEGY & BUSINESS DEVELOPMENT, BRISTOL MYERS SQUIBB COMPANY
Deal or No Deal? What to Know About Dealmaking Post-Pandemic
Bristol Myers Squibb
Princeton, New Jersey, United States
photo
Christopher Missling, PhD, MBA
CHIEF EXECUTIVE OFFICER, ANAVEX LIFE SCIENCES CORP.
Anavex Life Sciences
New York, New York, United States
photo
Edith Mitchell, MD
CLINICAL PROFESSOR OF MEDICINE AND MEDICAL ONCOLOGY, SIDNEY KIMMEL CANCER CENTER AT JEFFERSON
Cancer Collaborations: Accelerating Therapy Development & Commercialization
photo
Jomana Musmar, MS, PhD
PUBLIC HEALTH ADVISOR AND COMMITTEE MANAGER, OFFICE OF INFECTIOUS DISEASE AND HIV/AIDS POLICY, PRESIDENTIAL ADVISORY COMMITTEE ON COMBATING ANTIOBIOTIC RESISTANCE BACTERIA (PACCARB)
Big Idea Talk with the Presidential Advisory Committee on Combating Antiobiotic Resistance Bacteria (PACCARB)
photo
Shankar Musunuri, PhD, MBA
CHIEF EXECUTIVE OFFICER, OCUGEN
Ocugen Inc.
Malvern, Pennsylvania, United States
photo
Michael Nelson
CEO, INTROMMUNE THERAPEUTICS
Intrommune Therapeutics
New York, New York, United States
photo
Kevin Noonan, PhD
PARTNER - BIOTECHNOLOGY & PHARMACEUTICALS, MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
The Patent Policy Landscape, Post-COVID
Chicago, Illinois, United States
photo
Maggie O'Toole
CHIEF OPERATING OFFICER, LABCENTRAL
Driving Cross-Border Growth in Turbulent Times: Successes, Challenges and the Role of Ecosystems
Cambridge, Massachusetts, United States
photo
Tim Oldham, PhD
CEO AND MANAGING DIRECTOR, ADALTA PTY LTD.
AdAlta Ltd
Bundoora, Australia
photo
Deepa Pakianathan, PhD
MANAGING PARTNER, DELPHI VENTURES
Raising Capital Today, Part 1 - From Start-Up to pre-IPO
San Mateo, California, United States
photo
Pan Pan
ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, KLUS PHARMA, INC
KLUS Pharma
Cranbury, New Jersey, United States
photo
Yoon Jeong Park
PROFESSOR/CTO, NIBEC
NIBEC
Seoul,
photo
Sungjin Park
CEO, ONEGENE BIOTECHNOLOGY INC.
Onegene Biotechnology Inc.
Suwon-si, Gyeonggi-do,
photo
Jerry Parrott
PRESIDENT & CEO, BIOMARKER STRATEGIES, LLC
BioMarker Strategies, LLC
Rockville, Maryland, United States
photo
Andy Pasternak
EXECUTIVE VICE PRESIDENT, CHIEF STRATEGY OFFICER, HORIZON THERAPEUTICS
A Pipeline Built with Purpose – A Partnering Approach Designed to Fuel Innovation
Lake Forest, Illinois, United States
photo
Snehal Patel
CHIEF EXECUTIVE OFFICER, GREENWICH LIFESCIENCES
Greenwich LifeSciences
Sugar Land, Texas, United States
photo
Joseph Payne, MSc
FOUNDER, PRESIDENT & CEO, ARCTURUS THERAPEUTICS
Arcturus Therapeutics
San Diego, California, United States
photo
Adelene Perkins
CHAIR & CHIEF EXECUTIVE OFFICER, INFINITY PHARMACEUTICALS, INC.
Infinity Pharmaceuticals, Inc.
Cambridge, Massachusetts, United States
photo
Guillaume Pfefer
CEO, SENDA BIOSCIENCES
Senda Biosciences
Cambridge, Massachusetts, United States
photo
Richard Pops, PhD
CHAIRMAN & CEO, ALKERMES, INC.
FDA Town Hall
Waltham, Massachusetts, United States
photo
Geoff Porges, MBBS
DIRECTOR OF THERAPEUTICS RESEARCH, DIVERSIFIED BIOPHARMA, SVB LEERINK
Vaccine Business – Five minutes of fame or five-time Oscar winner?
photo
Christopher Porter
VICE PRESIDENT, GOVERNMENT AFFAIRS AND POLICY, TRAVERE THERAPEUTICS, INC.
The Burden of Rare Disease and Access to Treatments
San Diego, California, United States
photo
Steven Potts, PhD, MBA
COFOUNDER, CEO AND DIRECTOR, ONCOMYX THERAPEUTICS
OncoMyx Therapeutics
Phoenix, Arizona, United States
photo
Erik Pulkstenis, PhD
VICE PRESIDENT, DATA & STATISTICAL SCIENCES, ABBVIE
The Future of Clinical Trials: Lessons from COVID-19
North Chicago, Illinois,
photo
Lucinda Quan, JD
EXECUTIVE VICE PRESIDENT, CHIEF BUSINESS OFFICER & GENERAL COUNSEL, ALIGOS THERAPEUTICS, INC.
A More Perfect Partnership: State of the Pharma and Biotech Union
South San Francisco, California, United States
photo
Andrew Radin
CEO, TWOXAR
twoXAR Pharmaceuticals
Mountain View, California, United States
photo
Karthik Ramachandran
VP & FOUNDER, LIKARDA, LLC
Likarda, LLC
Kansas City, Missouri, United States
photo
Deborah Rathjen
CEO, CARINA BIOTECH
Carina Biotech
MAWSON LAKES, Australia
photo
Georges Rawadi
CEO, YSOPIA BIOSCIENCE
YSOPIA Bioscience
Bordeaux, France
photo
Amir Reichman, MBA, MENG
CEO, BIONDVAX PHARMACEUTICALS LTD
BiondVax Pharmaceuticals Ltd
Jerusalem, Israel
photo
Michelle Rice
CHIEF EXTERNAL AFFAIRS OFFICER, NATIONAL HEMOPHILIA FOUNDATION
Novel Reimbursement Approaches: Overcoming Barriers
photo
Aurélien Rizk
CEO, INTERAX BIOTECH AG
InterAx Biotech Ltd
Villigen, Switzerland
photo
Brian Roberts
LIFE SCIENCES PROGRAM MANAGER, LEIDOS LIFE SCIENCES
Leidos Life Sciences
Frederick, Maryland, United States
photo
Michael Robinson, MD
ALS PATIENT & ADVOCATE
Patient Perspectives: Elevating Our Voices to Advance Innovation
photo
Spiro Rombotis
PRESIDENT & CEO, CYCLACEL PHARMACEUTICALS, INC
Cyclacel Pharmaceuticals, Inc.
Berkeley Heights, New Jersey, United States
photo
Robert Rouse
HEAD OF US MARKET ACCESS, CSL BEHRING
Novel Reimbursement Approaches: Overcoming Barriers
photo
Angela Rusakova
PARTNER, ACILON CONSULTING
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
photo
Daniel Saltzman, PhD, MD
CHIEF OF PEDIATRIC SURGERY (U OF MN MED SCHOOL); CHIEF MEDICAL OFFICER (SALSPERA, LLC), UNIVERSITY OF MINNESOTA MEDICAL SCHOOL; SALSPERA, LLC
Salspera, LLC
Oakdale, Minnesota, United States
photo
Camille Samuels, MBA
PARTNER, VENROCK
A More Perfect Partnership: State of the Pharma and Biotech Union
Palo Alto, California, United States
photo
James Sapirstein
PRESIDENT & CHIEF EXECUTIVE OFFICER, AZURRX BIOPHARMA INC.
AzurRx BioPharma
Brooklyn, New York, United States
photo
Niranjan Sardesai
PRESIDENT & CEO, FOUNDER, GENEOS THERAPEUTICS, INC.
Geneos Therapeutics
Plymouth Meeting, Pennsylvania, United States
photo
Jay Schnitzer, PhD, MD
VICE PRESIDENT, CHIEF TECHNOLOGY OFFICER, AND CHIEF MEDICAL OFFICER, MITRE
Pandemic and Profit: Why there must be a business model that works for the future
photo
Catherine Schulte
SENIOR RESEARCH ANALYST | LIFE SCIENCES & DIAGNOSTICS, INSTITUTIONAL EQUITIES & RESEARCH, BAIRD
Fireside Chat with CEO and Co-Founder of Twist Bioscience, Dr. Emily Leproust
photo
Duane Schulthess
MANAGING DIRECTOR, VITAL TRANSFORMATION
Reference Pricing’s impact on Biotech Innovation: Weighing the public purse and private investments
Wezembeek Oppem, Belgium
photo
Alicia Secor, MBA
PRESIDENT AND CEO, ATALANTA THERAPEUTICS
A More Perfect Partnership: State of the Pharma and Biotech Union
photo
Alan Shaw, PhD
PRESIDENT, CEO & CO-FOUNDER, CALYSTA
Innovator Spotlight with Dr. Alan Shaw, President, CEO and Co-Founder of Calysta
Menlo Park, California, United States
photo
Richard Shea, MBA
CHIEF EXECUTIVE OFFICER, BASKING BIOSCIENCES, INC.
Basking Biosciences
Cary, North Carolina, United States
photo
Paul Sheives
DIRECTOR, FEDERAL HEALTH POLICY & REIMBURSEMENT, ROCHE
Diagnosing the Future: The Impact of the COVID-19 Pandemic on Diagnostics
South San Francisco, California, United States
photo
Chiachin Sheu
SECRETARY, SIMPSON BIOTECH CO., LTD.
Simpson Biotech
Taoyuan, Taiwan
photo
Leonard Sigal
CHIEF MEDICAL OFFICER , ASERTON THERAPEUTICS
Aserton Therapeutics
Stockbridge, Massachusetts, United States
photo
Iain Simpson
DIRECTOR – FRONT-END INNOVATION AND CONNECTED HEALTH PHILLIPS-MEDISIZE , PHILLIPS-MEDISIZE
Phillips-Medisize
Cambridge, United Kingdom
photo
Patrick Sin-Chan
PARTNERSHIP MANAGER, OWKIN
Owkin
New York, New York, United States
photo
Mark Sirgo, PharmD
CHIEF EXECUTIVE OFFICER, ARUNA BIO
Aruna Bio
Athens, Georgia, United States
photo
Henry Skinner
CEO, AMR ACTION FUND
Fixing the Economics of Antibiotic Development—Before It’s Too Late
photo
Yochi Slonim
CO-FOUNDER AND CEO, ANIMA BIOTECH INC.
Anima Biotech
Bernardsville, New Jersey, United States
photo
Pete Smith
CEO, AFFINITY BIOSCIENCES PTY LTD
Affinity Biosciences
Melbourne, Australia
photo
Robert Smith
SENIOR VICE PRESIDENT, GLOBAL GENE THERAPY BUSINESS, RARE DISEASE, PFIZER, INC.
Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities
photo
Joe Smyser
CEO, THE PUBLIC GOOD PROJECTS
Building Vaccine Confidence: Evidence and Emotion
photo
Tamas Sohajda
R&D DIRECTOR, CYCLOLAB
Cyclolab
Budapest, Hungary
photo
Kumar Srinivasan
VP, GLOBAL HEAD OF BUSINESS DEVELOPMENT AND LICENSING, BIOPHARMACEUTICALS R&D, ASTRAZENECA PHARMACEUTICALS
The Next Big Deal: Market Outlook for 2021 and Beyond
Waltham, Massachusetts, United States
photo
Lilly Stairs
INTERIM PRESIDENT & CEO, AMERICAN AUTOIMMUNE RELATED DISEASES ASSOCIATION
Patient Perspectives: Elevating Our Voices to Advance Innovation
photo
Leah Stilwell
DIRECTOR OF BUSINESS DEVELOPMENT, ASYMCHEM
Asymchem
Morrisville, North Carolina, United States
photo
Today Su
CEO, GOLDEN BIOTECHNOLOGY CORP.
Golden Biotechnology Corp.
New Taipei City, Taiwan
photo
Mark Suseck
CEO, VIVACITAS ONCOLOGY INC
Vivacitas Oncology Inc
Walnut Creek, California, United States
photo
Alex Szidon, PhD
VICE PRESIDENT, HEAD OF BUSINESS DEVELOPMENT FOR GRED, PHARMA PARTNERING, GENENTECH AND ROCHE
A More Perfect Partnership: State of the Pharma and Biotech Union
South San Francisco, California, United States
photo
Laszlo Szilagyi, PhD
INTERNATIONAL LICENCE-OUT MANAGER, EGIS PHARMACEUTICALS
EGIS Pharmaceuticals PLC
Budapest, Hungary
photo
Marco Taglietti
PRESIDENT & CHIEF EXECUTIVE OFFICER, SCYNEXIS, INC.
SCYNEXIS, Inc.
Jersey City, New Jersey, United States
photo
Hideyuki Tanaka
SR. DIRECTOR, AJINOMOTO BIO-PHARMA SERVICES
Ajinomoto Co., Inc.
San Diego, California, United States
photo
Nikolaos Tezapsidis
PRESIDENT & CEO, NEUROTEZ, INC.
Neurotez Inc.
Bridgewater, New Jersey, United States
photo
Marc Thibonnier
FOUNDER & PRESIDENT, APTAMIR THERAPEUTICS, INC.
AptamiR Therapeutics, Inc.
Naples, Florida, United States
photo
David Thomas
VICE PRESIDENT, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION
Big Idea Talk with David Thomas, BIO's Vice President of Industry Research: A COVID Pipeline Update
Emerging Therapeutic Company Investment, By the Numbers
Washington, United States
photo
Camelia Thompson
SENIOR DIRECTOR, SCIENCE & REGULATORY AFFAIRS, BIOTECHNOLOGY INNOVATION ORGANIZATION
This is the true story…of Real-World Evidence (RWE) in COVID-19 Therapeutics
Washington, United States
photo
Wenzhi Tian
CEO, IMMUNEONCO BIOPHARMA CO., LTD
ImmuneOnco Biopharma
Shanghai, China
photo
Laurel Todd
VP, GOVERNMENT AFFAIRS & POLICY, IOVANCE BIOTHERAPEUTICS
Novel Reimbursement Approaches: Overcoming Barriers
Wilmington, Delaware, United States
photo
Philip Toleikis
PRESIDENT & CEO, SERNOVA CORP.
Sernova Corp.
London, Ontario, Canada
photo
Pascal Touchon
PRESIDENT & CEO, ATARA BIOTHERAPEUTICS
Atara Biotherapeutics, Inc.
South San Francisco, California, United States
photo
Thomas Triomphe
EXECUTIVE VICE PRESIDENT, SANOFI PASTEUR
Fireside Chat with Thomas Triomphe, Executive Vice President, Sanofi Pasteur
photo
Joseph Tucker
CEO, MAGICMED INDUSTRIES INC.
MagicMed Industries Inc.
Boston, Massachusetts, United States
photo
Arda Ural
AMERICAS LEADER FOR LIFE SCIENCES, ERNST & YOUNG, LLP
Raising Capital Today, Part 2 - SPAC/IPO Paths to Public Markets
Allendale, New Jersey, United States
photo
Rajeev Venkayya
PRESIDENT, VACCINE BUSINESS UNIT, TAKEDA PHARMACEUTICALS AMERICA, INC.
Global Pandemic Preparedness – It takes a globe....
Cambridge, Massachusetts, United States
photo
Chantal Vogels, PhD
ASSOCIATE RESEARCH SCIENTIST, DEPARTMENT OF EPIDEMIOLOGY OF MICROBIAL DISEASES, YALE SCHOOL OF PUBLIC HEALTH
Innovator Spotlight: Chantal Vogels, Yale School of Public Health, developer of Saliva Test for NBA
photo
Timothy Walbert
CHAIRMAN, PRESIDENT & CEO, HORIZON THERAPEUTICS
A Pipeline Built with Purpose – A Partnering Approach Designed to Fuel Innovation
Lake Forest, Illinois, United States
photo
Jan Walter
SENIOR IP ADVISER, ECONOMIC & TRADE TEAM, UK MISSION GENEVA
The Patent Policy Landscape, Post-COVID
photo
Reginald Ware
CHIEF EXECUTIVE OFFICER, BLACKDOCTOR.ORG
Building Vaccine Confidence: Evidence and Emotion
photo
Blake Wise
CHIEF EXECUTIVE OFFICER, NOVOME BIOTECHNOLOGIES, INC.
Novome Biotechnologies, Inc.
South San Francisco, California, United States
photo
Herbert (chung-Hsiun) Wu
DIRECTOR, BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES PROMOTION OFFICE (BPIPO)
Taiwan Delegation
photo
Sylvia Wulf
PRESIDENT & CEO, AQUABOUNTY TECHNOLOGIES, INC.
Reimagining the Food System to Enhance Resilience & Nutrition Access
Maynard, Massachusetts, United States
photo
Sean Xie
FOUNDER/CSO AND CHAIRMAN OF THE BOARD, ID4PHARMA
ID4pharma
Bridgeville, Pennsylvania, United States
photo
Kewei Xie
CBO, ABBISKO THERAPEUTICS CO. LTD.
Abbisko Therapeutics
Verona, Wisconsin, United States
photo
JIN SAN YOO
CEO AND PRESIDENT, PHARMABCINE, INC.
PharmAbcine Inc.
Daejeon,
photo
Lihua Zheng, PhD, JD
FOUNDER AND CBO, ANHEART THERAPEUTICS CO., LTD.
AnHeart Therapeutics
New York, New York, United States
photo
Michael Zhou
CHIEF MEDICAL SCIENTIST, ASCENT INNOVATION
ASCENT INNOVATION
Shanghai, China
photo
Greg Zinkl
SENIOR PATENT COUNSEL, GENENTECH AND ROCHE
Lessons from COVID on Innovation, Collaboration & Enforcement
Load More